GIORDANO, Claudia
 Distribuzione geografica
Continente #
NA - Nord America 314
EU - Europa 168
AS - Asia 61
AF - Africa 16
SA - Sud America 1
Totale 560
Nazione #
US - Stati Uniti d'America 313
IT - Italia 123
CN - Cina 23
NL - Olanda 18
VN - Vietnam 18
CI - Costa d'Avorio 16
SG - Singapore 16
DE - Germania 7
SE - Svezia 7
FI - Finlandia 3
FR - Francia 3
GB - Regno Unito 3
HK - Hong Kong 2
IN - India 2
RU - Federazione Russa 2
CA - Canada 1
CL - Cile 1
GR - Grecia 1
IE - Irlanda 1
Totale 560
Città #
Chandler 95
Naples 42
Ashburn 30
Amsterdam 18
Dong Ket 18
Lawrence 12
Millbury 11
Beijing 9
Singapore 9
Des Moines 7
Nocera Inferiore 7
Norwalk 7
Boston 5
Napoli 5
Shanghai 5
Wilmington 5
Rome 4
Hanover 3
Pagani 3
Augusta 2
Bergamo 2
Campagna 2
Gesualdo 2
Hong Kong 2
Lappeenranta 2
Marano 2
Marano di Napoli 2
Milan 2
Nanchang 2
Seattle 2
Stockholm 2
Agropoli 1
Arzano 1
Changsha 1
Dearborn 1
Dublin 1
Edinburgh 1
Fairfield 1
Gambatesa 1
Gurgaon 1
Hebei 1
Helsinki 1
Jiaxing 1
Kronberg 1
Leawood 1
Magnago 1
Modica 1
Nanjing 1
Nanning 1
Ottawa 1
Paris 1
Portland 1
Pozzuoli 1
Princeton 1
Pune 1
Redwood City 1
Santa Maria Capua Vetere 1
Thessaloníki 1
Torino 1
Washington 1
Woodbridge 1
Zhengzhou 1
Totale 350
Nome #
(1-3)-β-d-Glucan serum increase and small-airway-invasive radiological findings as early signs of pulmonary aspergillosis in high-risk hematologic patients in the posaconazole era: preliminary observations 81
Tenofovir vs lamivudine for the prevention of hepatitis B virus reactivation in advanced-stage DLBCL 60
A Frontline Approach With Peripherally Inserted Versus Centrally Inserted Central Venous Catheters for Remission Induction Chemotherapy Phase of Acute Myeloid Leukemia: A Randomized Comparison 58
Hashimoto Thyroiditis in Primary Thyroid Non-Hodgkin Lymphoma 48
Adding hydroxyurea in combination with ruxolitinib improves clinical responses in hyperproliferative forms of myelofibrosis 42
Correspondence in reference to the previously published Epub manuscript by Peter Hokland et al. 'How I treat advanced Hodgkin lymphoma - a global view'. Br J Haematol. 2020;190:837-50 42
Liposomal doxorubicin supercharge-containing front-line treatment in patients with advanced-stage diffuse large B-cell lymphoma or classical Hodgkin lymphoma: Preliminary results of a single-centre phase II study 41
Rituximab-containing risk-adapted treatment strategy in nodular lymphocyte predominant hodgkin lymphoma: 7-years follow-up 33
Regarding "Hepatitis B surface antigen positivity is an independent unfavorable prognostic factor in diffuse large B-cell lymphoma in the rituximab era" 32
A Roadmap for a Comprehensive Diagnostic Approach to Fine Needle Cytology of Lymph Node Metastases 30
Impact of COVID-19 pandemic on 2-[18F]FDG PET/CT imaging work-flow in a single medical institution: comparison among the three Italian waves 30
Sjögren Syndrome in Primary Salivary Gland LymphomaA Systematic Review and Meta-Analysis 25
Correspondence in reference to previously published manuscript: "Faouzi Djebbari et al. Efficacy and infection morbidity of front-line immuno-chemotherapy in follicular lymphoma. Eur J Haematol 2020; 105: 667-671." 23
Correspondence in reference to the previously published Epub manuscript: “Murt Ahmet et al. Hepatitis B reactivation in hematopoietic stem cell transplanted patients: 20 years of experience of a single center from a middle endemic country. Annals of Hematology 2020; 99: 2671-2677” 23
Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paper 18
Lamivudine 24-month-long prophylaxis is a safe and efficient choice for the prevention of hepatitis B virus reactivation in HBsAg-negative/HBcAb-positive patients with advanced DLBCL undergoing upfront R-CHOP-21 13
Totale 599
Categoria #
all - tutte 2.344
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.344


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193 0 0 0 0 0 0 0 0 0 0 0 3
2019/202055 6 0 2 6 4 0 0 13 4 8 11 1
2020/202162 1 0 3 3 7 2 0 11 12 2 2 19
2021/2022118 1 2 4 1 5 4 9 2 4 10 53 23
2022/2023208 14 10 14 10 33 28 2 29 34 21 9 4
2023/2024141 6 15 21 12 4 8 3 34 4 3 19 12
Totale 599